Generex Biotechnology Corp. 18m · With 25 con
Post# of 36537
(Total Views: 466)
Posted On: 11/21/2020 8:19:34 PM
Generex Biotechnology Corp.
18m ·
With 25 confirmed cases and over 400 suspected cases, #COVID19 #reinfection is no longer just a theory. Developing a vaccine that has the ability to provide long term immunity from COVID-19 is key. "Here, durability is an X factor."
#COVID19 #biotech #coronavirusvaccine #sarscov2 #immunology #immunotherapy #tcells #biotechnology #clinicaltrial #Iikeypeptide
https://www.forbes.com/sites/joshuacohen/2020...rclwP1Y9Cs
18m ·
With 25 confirmed cases and over 400 suspected cases, #COVID19 #reinfection is no longer just a theory. Developing a vaccine that has the ability to provide long term immunity from COVID-19 is key. "Here, durability is an X factor."
#COVID19 #biotech #coronavirusvaccine #sarscov2 #immunology #immunotherapy #tcells #biotechnology #clinicaltrial #Iikeypeptide
https://www.forbes.com/sites/joshuacohen/2020...rclwP1Y9Cs
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼